Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Textron enters its October 29 earnings window with the short-unwind story from last week showing early signs of stalling, while the Street's most recent analyst move points directly at valuation risk.
The most notable development this week is a fresh target cut from a bellwether firm. Citigroup's John Godyn lowered his price target on Textron to $86 from $99 today, keeping a Neutral rating. That move stands out because it brings Citi's target much closer to the current price of $75.53, and it narrows the implied upside gap that the broader consensus still shows. The mean analyst target across all active coverage is $100.60, which puts the theoretical return at roughly 33% from here. But that consensus figure is being dragged up by older, staler targets. TD Cowen cut to $105 in July, JP Morgan and UBS raised their targets in May to $105 and $100 respectively, while Jefferies holds a Buy with a $110 target. The direction of travel in the last two months has been downward, with Citi's fresh $86 the lowest named target now on the board. The Street is not yet outright bearish, but it is becoming more cautious.
Short positioning adds a wrinkle to that picture. After the sharp unwind documented last week, where bears cut from roughly 7.5 million shares to 6.6 million in a matter of days, short interest has nudged slightly higher this week. Shares short ticked up about 1.3% on Tuesday to 6.48 million, or 3.7% of the free float. That is still well below the September 11 peak near 8.8 million, so the broader unwind remains intact. But the incremental rebuild is worth noting, and it coincides with Citi's target cut, which landed on the same day. Borrow conditions give shorts no friction: availability is 1,318%, meaning there are more than 13 shares available to lend for every one currently borrowed, comfortably above the 52-week low of 518%. Cost to borrow has edged up 13% on the week to 0.49%, still well within normal ranges for a name of this size. Nothing in the lending market constrains a rebuild if sentiment sours further into the print.
Options positioning is the clearest bullish signal left in the setup. The put/call ratio is 0.28, still well below its 20-day average of 0.40 and close to the 52-week low of 0.21. Call demand is running at roughly double the level of puts, making this one of the most bullishly skewed options markets Textron has seen all year. The shift is stark when set against the readings from early September, when the PCR was above 0.57 for weeks. Whatever drove that hedging rush has largely unwound. Options traders, for now, are positioned for upside into earnings.
The stock's valuation context is mixed. The EV/EBITDA multiple is around 7.9x, down modestly over the past month, and the P/E is near 10.7x, also drifting lower. Both are consistent with a deep-value framing, and the EV/EBIT factor score ranks in the 76th percentile of the ORTEX universe. But earnings momentum tells a less encouraging story: the EPS momentum scores over both 30-day and 90-day windows rank in the bottom 40% of the market, and forward earnings growth sits similarly below the median. Jefferies remains the lone explicit bull with a $110 Buy target, but the broader analyst picture is a cluster of Neutrals and Holds with targets now ranging from $86 to $110.
Textron is also lagging its peer group again this week. Curtiss-Wright gained 3.7% on the week and Ducommun was up 2.4%, while Textron slipped 2.7%. The stock is down about 4.5% over the past month against a sector that has generally held up better. Wikipedia attention spiked in early September, with a z-score of 2.1 at its September 9 peak, suggesting a brief surge in retail interest that has since faded from the data.
With October 29 now 22 days away, the next focal point is whether the Citi target cut prompts further downward consensus revision before the print, or whether the bullish options positioning proves the more prescient read on what Textron's Q3 numbers will show.
See the live data behind this article on ORTEX.
Open TXT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
